| 6-(4-(Trifluoromethoxy)phenyl)-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridine | IC50 | 250.0 [1], 333.0 [2], 3000.0 [3], 10000.0 [4] |
| 5-(4-Chlorophenyl)-N-(3,5-dimethoxyphenyl)furan-2-carboxamide | IC50 | 2000.0 [1], 7340.0 [2], 7440.0 [3], 32820.0 [4] |
| 3-Cyano-4-[2-(2-methylpyrazol-3-yl)phenoxy]-N-(1,3-thiazol-2-yl)benzenesulfonamide | IC50 | 10000.0 [1], 30000.0 [2] |
| [3-(Dimethylamino)-4-methoxyphenyl]-(7-methoxyspiro[5H-pyrrolo[1,2-a]quinoxaline-4,4'-piperidine]-1'-yl)methanone | IC50 | 351.0 [1], 572.0 [2], 10485.0 [3] |
| 4-[2-Methoxy-4-(trifluoromethyl)phenyl]-N-(1,3-thiazol-2-yl)quinazoline-7-sulfonamide | IC50 | 16000.0 [1], 30000.0 [2] |
| 5-Chloro-2-fluoro-4-[(4-hydroxycyclohexyl)methylamino]-N-(1,3-thiazol-2-yl)benzenesulfonamide | IC50 | 156.0 [1], 380.0 [2], 730.0 [3], 1300.0 [4] |
| 2-[(3-Methyl-1,2,4-oxadiazol-5-yl)methyl]-6-[4-(trifluoromethoxy)phenyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one | IC50 | 1330.0 [1], 1900.0 [2], 10000.0 [3] |
| Lamotrigine | IC50 | 39810.72 [1], 62000.0 [2], 100000.0 [3] |
| Tetracaine | IC50 | 200.0 [1], 530.0 [2], 650.0 [3] |
| Propafenone | IC50 | 1190.0 [1], 3300.0 [2], 5000.0 [3] |
| Mexiletine | IC50 | 13000.0 [1], 58000.0 [2], 420000.0 [3] |
| Dofetilide | IC50 | 300000.0 [1], 316227.77 [2], 630957.34 [3] |
| CID 46840946 | IC50 | 11.0 [1], 10000.0 [2], 25000.0 [3] |
| N-[2-Methyl-3-[[4-[4-[[4-(trifluoromethoxy)phenyl]methoxy]piperidin-1-yl]-1,3,5-triazin-2-yl]amino]phenyl]acetamide | IC50 | 1100.0 [1], 5200.0 [2], 10000.0 [3] |
| Nav1.7-IN-3 | IC50 | 2.2 [1], 30000.0 [2] |
| CID 118734430 | IC50 | 5000.0 [1], 10000.0 [2] |
| CID 118734436 | IC50 | 5000.0 [1], 10000.0 [2] |
| CID 118734482 | IC50 | 400.0 [1], 2300.0 [2] |
| CID 118734547 | IC50 | 5000.0 [1], 8800.0 [2] |
| 4-(1-Adamantylmethoxy)-5-chloro-2-fluoro-N-methylsulfonylbenzamide | IC50 | 1070.0 [1], 1900.0 [2] |
| 4-[2-Methoxy-4-(trifluoromethyl)phenyl]-N-(1,3-thiazol-2-yl)-2,3-dihydro-1,4-benzoxazine-7-sulfonamide | IC50 | 1990.0 [1], 2000.0 [2] |
| 2-N-[4-(4-Chlorophenoxy)phenyl]-1,3,5-triazine-2,4-diamine | IC50 | 200.0 [1], 3200.0 [2], 10000.0 [3] |
| N-[[5-[1-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]benzamide | IC50 | 19000.0 [1], 69000.0 [2], 100000.0 [3] |
| N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamide | IC50 | 920.0 [1], 14800.0 [2], 36000.0 [3] |
| 2-N-[4-[4-(Trifluoromethoxy)phenoxy]phenyl]pyrazine-2,6-diamine | IC50 | 1260.0 [1], 1500.0 [2], 10000.0 [3] |
| Phenytoin | IC50 | 49000.0 [1], 100000.0 [2] |
| Sildenafil | IC50 | 501187.23 [1], 1258925.41 [2] |
| Quinidine | IC50 | 6900.0 [1], 16600.0 [2] |
| Moxifloxacin | IC50 | 39810.72 [1], 251188.64 [2] |
| Everolimus | IC50 | 199526.23 [1], 630957.34 [2] |
| Sunitinib | IC50 | 15848.93 [1], 39810.72 [2] |
| Dasatinib | IC50 | 100000.0 [1], 398107.17 [2] |
| Duloxetine | IC50 | 7943.28 [1], 15848.93 [2] |
| Nelfinavir | IC50 | 79432.82 [1], 501187.23 [2] |
| Tadalafil | IC50 | 125892.54 [1], 158489.32 [2] |
| Sitagliptin | IC50 | 630957.34 [1], 794328.23 [2] |
| Nilotinib | IC50 | 1000000.0 [1], 5011872.34 [2] |
| Raltegravir | IC50 | 316227.77 [1], 1584893.19 [2] |
| Darunavir | IC50 | 39810.72 [1], 100000.0 [2] |
| Vardenafil | IC50 | 199526.23 [1], 2511886.43 [2] |
| Tolterodine | IC50 | 6309.57 [1], 31622.78 [2] |
| Nebivolol | IC50 | 6309.57 [1], 7943.28 [2] |
| Maraviroc | IC50 | 630957.34 [1], 1000000.0 [2] |
| Deferasirox | IC50 | 79432.82 [1], 501187.23 [2] |
| Paliperidone | IC50 | 25118.86 [1], 158489.32 [2] |
| Etravirine | IC50 | 501187.23 [1], 3981071.71 [2] |
| Alfuzosin | IC50 | 199526.23 [1], 1584893.19 [2] |
| Eltrombopag | IC50 | 158489.32 [1], 316227.77 [2] |
| Ambrisentan | IC50 | 1000000.0 [1], 1258925.41 [2] |
| Desvenlafaxine | IC50 | 199526.23 [1], 316227.77 [2] |
| Oliceridine | IC50 | 4700.0 [1], 16500.0 [2] |
| F-15845 Free base | IC50 | 2560.0 [1], 5770.0 [2] |
| 3-(2-Aminopropoxy)-2,4-dimethylphenol | IC50 | 30000.0 [1], 174000.0 [2] |
| Auglurant | IC50 | 100000.0 [1] |
| 2,2-Diphenyl-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]acetamide | IC50 | 9200.0 [1], 10000.0 [2] |
| (2S)-2-[[(2S)-2-[[(2S)-6-Amino-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(1R,4S,7S,13S,16R,21R,24S,27S,30S,33S,36S,39S,42R,45S,48S,51S,54S,57S,60R,65R,68S,71S,74S)-27,57-bis(4-aminobutyl)-21-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-24-(3-amino-3-oxopropyl)-54,74-bis(3-carbamimidamidopropyl)-13,51-bis(2-carboxyethyl)-45-(carboxymethyl)-39-[(1R)-1-hydroxyethyl]-48-(hydroxymethyl)-30,36,68-tris(1H-indol-3-ylmethyl)-71-(2-methylpropyl)-7,33-bis(2-methylsulfanylethyl)-3,6,9,12,15,22,25,28,31,34,37,40,43,46,49,52,55,58,67,70,73,76,81-tricosaoxo-4-propan-2-yl-18,19,62,63,78,79-hexathia-2,5,8,11,14,23,26,29,32,35,38,41,44,47,50,53,56,59,66,69,72,75,82-tricosazatricyclo[40.34.4.216,60]dooctacontane-65-carbonyl]amino]hexanoyl]amino]hexanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid | IC50 | 79.0 [1], 90.0 [2] |
| 2-(2-Amino-1,3-thiazol-4-yl)-N-[4-[[(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl]methyl]phenyl]acetamide | IC50 | 30000.0 [1] |
| 1-[2-Methoxy-4-[3-(trifluoromethyl)phenyl]phenyl]-2-oxo-N-pyrimidin-2-ylquinoline-6-sulfonamide | IC50 | 30000.0 [1], 42500.0 [2] |
| 4-[[(3S,4R)-4-(4-Chlorophenyl)piperidin-3-yl]methoxy]-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | IC50 | 10000.0 [1] |
| CID 118734434 | IC50 | 5000.0 [1] |
| CID 118734437 | IC50 | 27000.0 [1] |
| CID 118734438 | IC50 | 5000.0 [1] |
| CID 118734439 | IC50 | 5000.0 [1] |
| CID 118734440 | IC50 | 5000.0 [1] |
| CID 118734441 | IC50 | 5000.0 [1] |
| CID 118734442 | IC50 | 5000.0 [1] |
| CID 118734443 | IC50 | 5000.0 [1] |
| CID 118734444 | IC50 | 5000.0 [1] |
| CID 118734445 | IC50 | 5000.0 [1] |
| CID 118734446 | IC50 | 20000.0 [1] |
| CID 118734447 | IC50 | 20000.0 [1] |
| CID 118734448 | IC50 | 5000.0 [1] |
| CID 118734449 | IC50 | 20000.0 [1] |
| CID 118734450 | IC50 | 5000.0 [1] |
| CID 118734451 | IC50 | 4700.0 [1] |
| CID 118734452 | IC50 | 5000.0 [1] |
| CID 118734456 | IC50 | 5000.0 [1] |
| CID 118734458 | IC50 | 5000.0 [1] |
| CID 118734459 | IC50 | 5000.0 [1] |
| CID 118734460 | IC50 | 5000.0 [1] |
| CID 118734461 | IC50 | 5000.0 [1] |
| CID 118734489 | IC50 | 500.0 [1], 3500.0 [2] |
| CID 118734490 | IC50 | 5000.0 [1], 10000.0 [2] |
| CID 118734548 | IC50 | 5000.0 [1], 10000.0 [2] |
| 1-[2-[3-(4-Benzhydrylpiperazin-1-yl)-2-hydroxypropoxy]-5-fluorophenyl]-3-phenylpropan-1-one | IC50 | 5000.0 [1] |
| 1-[2-[2-Hydroxy-3-[4-(4-methylphenyl)piperazin-1-yl]propoxy]phenyl]-3-phenylpropan-1-one | IC50 | 5000.0 [1] |
| Unii-403N302X2Y | IC50 | 12589.25 [1], 13000.0 [2] |
| (6S)-N-[4-[[(2S,5R)-5-[(R)-Hydroxy(pyridin-3-yl)methyl]pyrrolidin-2-yl]methyl]phenyl]-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole-6-carboxamide | IC50 | 30000.0 [1] |
| 1-Methyl-3-[2-(2-methylpyrazol-3-yl)-4-(trifluoromethyl)phenyl]-N-(1,2,4-thiadiazol-5-yl)indole-6-sulfonamide | IC50 | 10000.0 [1], 30000.0 [2] |
| 4-[2-(2-Amino-3H-benzimidazol-5-yl)-4-chlorophenoxy]-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | IC50 | 10000.0 [1] |
| 4-[2-(3-Amino-1,2-benzoxazol-5-yl)-4-chlorophenoxy]-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | IC50 | 1000.0 [1], 1380.0 [2] |
| (4R)-N-[4-[[(2S,5R)-5-[(R)-Hydroxy(pyridin-3-yl)methyl]pyrrolidin-2-yl]methyl]phenyl]-5,6-dihydro-4H-cyclopenta[d][1,3]thiazole-4-carboxamide | IC50 | 30000.0 [1] |
| Tert-butyl 2-amino-4-[3-(1H-indole-2-carbonylamino)phenyl]imidazole-1-carboxylate | IC50 | 30000.0 [1] |
| 3-Cyano-4-[2-[2-[(2-piperidin-4-ylethylamino)methyl]pyridin-4-yl]-4-[3-(trifluoromethyl)phenyl]phenoxy]-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | IC50 | 2000.0 [1], 12797.25 [2] |
| 1-[2-Methoxy-4-(trifluoromethyl)phenyl]-2-oxo-N-(1,3-thiazol-2-yl)quinoline-6-sulfonamide | IC50 | 30000.0 [1] |
| CID 127045799 | IC50 | 5000.0 [1], 10000.0 [2] |
| CID 127045811 | IC50 | 5000.0 [1], 10000.0 [2] |
| CID 127046243 | IC50 | 5000.0 [1], 10000.0 [2] |
| CID 127046252 | IC50 | 5000.0 [1], 15900.0 [2] |
| CID 127046253 | IC50 | 1000.0 [1], 3500.0 [2] |